0.3995

2.08% -0.0085

Immunoprecise Antibodies Ltd (IPA)

Overview News Price History Option Chain Why IPA Down? Discussions Forecast Stock Split

Immunoprecise Antibodies Ltd stock is traded at $0.3995, with a volume of 242.69K. It is down -2.08% in the last 24 hours and down -41.09% over the past month. ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.

Previous Close:

$0.408

Open:

$0.392

24h Volume:

242.69K

Relative Volume:

0.47

Market Cap:

$10.96M

Revenue:

$16.77M

Net Income/Loss:

$-11.87M

P/E Ratio:

-0.6382

EPS:

-0.626

Net Cash Flow:

$-5.90M

1W Performance:

+3.52%

1M Performance:

-41.09%

6M Performance:

-64.01%

1Y Performance:

-72.06%

1-Day Range:

$0.3604

$0.41

1-Week Range:

$0.3248

$0.415

52-Week Range:

$0.3248

$2.60

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name

Immunoprecise Antibodies Ltd

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

Address

Employee

101

Twitter

Next Earnings Date

2024-09-16

Latest SEC Filings

IPA's Discussions on Twitter

Compare IPA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IPA Immunoprecise Antibodies Ltd	0.3995	10.96M	16.77M	-11.87M	-5.90M	-0.626
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-22	Initiated	H.C. Wainwright	Buy
Oct-25-21	Initiated	The Benchmark Company	Buy

Immunoprecise Antibodies Ltd Stock (IPA) Latest News

Nov 24, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Stock's 45% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Nov 24, 2024

Nov 18, 2024

Immunoprecise Antibodies Ltd. Announces Resignation of Barry A. Springer from Board - Marketscreener.com

Nov 18, 2024

Nov 13, 2024

ImmunoPrecise's Breakthrough Cancer Treatment Shows Promise in $20.7B ADC Market | IPA Stock News - StockTitan

Nov 13, 2024

Nov 05, 2024

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - BioSpace

Nov 05, 2024

Oct 28, 2024

ImmunoPrecise Pummeled Despite Advancing Anti-Aging Research with Mayo - Baystreet.ca

Oct 28, 2024

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire

Oct 28, 2024

Oct 24, 2024

ImmunoPrecise Antibodies Announces Annual Meeting Plans - TipRanks

Oct 24, 2024

Oct 21, 2024

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - BioSpace

Oct 21, 2024

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology

Oct 21, 2024

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design - Business Wire

Oct 10, 2024

Oct 09, 2024